Ethan A. Huff
Many medical professionals and members of the general public are losing faith in the credibility of the clinical trial and drug approval process, and rightfully so in light of all the corporate corruption and criminal behavior that has recently come to light. Two new papers published in the New England Journal of Medicine (NEJM) suggest that drug industry corruption is so pervasive nowadays that even the most rigorously-conducted studies and trials are not being taken seriously by many doctors.
Over the past three years, nearly every major drug company on the planet has been convicted of some kind of criminal behavior, whether it is fudging drug safety data; pushing drugs for off-label uses; bribing doctors and medical professionals to prescribe dangerous drugs; or conducting fraudulent clinical trials. Collectively, these companies have been forced to pay roughly $11 billion in fines for these and other crimes…
View original post 253 more words